GB2068225A - Dermatological compositions containing hydrogen peroxide - Google Patents

Dermatological compositions containing hydrogen peroxide Download PDF

Info

Publication number
GB2068225A
GB2068225A GB8003430A GB8003430A GB2068225A GB 2068225 A GB2068225 A GB 2068225A GB 8003430 A GB8003430 A GB 8003430A GB 8003430 A GB8003430 A GB 8003430A GB 2068225 A GB2068225 A GB 2068225A
Authority
GB
United Kingdom
Prior art keywords
composition according
acid
hydrogen peroxide
composition
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB8003430A
Other versions
GB2068225B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QUINODERN Ltd
Original Assignee
QUINODERN Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QUINODERN Ltd filed Critical QUINODERN Ltd
Priority to GB8003430A priority Critical patent/GB2068225B/en
Priority to AU71426/81A priority patent/AU7142681A/en
Publication of GB2068225A publication Critical patent/GB2068225A/en
Application granted granted Critical
Publication of GB2068225B publication Critical patent/GB2068225B/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/22Peroxides; Oxygen; Ozone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/40Peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

A dermatological composition, for treating skin conditions such as acne contains hydrogen peroxide buffered to a pH of less than 7 in the form of a non-greasy single phase aqueous gel. The buffer may be selected from lactic acid, citric acid, tartaric acid, maleic acid, hydroxysuccinic acid, potassium acid phosphate, sodium and potassium acid citrate and sodium and potassium acid tartrate.

Description

SPECIFICATION Dermatological compositions The invention relates to dermatological com positions containing hydrogen peroxide. The invention is primarily concerned with such compositions for human therapeutic use. It is however to be understood that the invention is not intended to be limited to such use and thus for example compositions according to the invention may be used in a veterinary rather than a human context and/or may be of cosmetic rather than therapeutic effect.
Hydrogen peroxide has a well-known therapeutic and cosmetic effect in a dermatological context due to its ability to make available free oxygen in contact with the skin. Further, hydrogen peroxide is a readily available and relatively inexpensive substance which need only be used in small quantities for dermatological purposes due to the high proportion of available oxygen which it contains. In these respects therefore hydrogen peroxide is a desirable substance for dermatological use.In other respects, however, hydrogen peroxide has disadvantages, in particular due to the fact that the substance is very unstable, due to the possible damage to skin tissue which may be caused if the skin is exposed to an unduly large amount of hydrogen peroxide, and due to the fact that hydrogen peroxide had a high surface tension and therefore tends not to spread easily on the skin and make intimate contact therewith.
In our prior Patent 1,539,771, there is disclosed a dermatological composition containing hydrogen peroxide with which the above-mentioned disadvantages can be avoided or at least appreciably reduced. More specifically, said prior Patent describes a dermatological composition in the form of a cream, lotion or gel comprising an oil medium dispersed in an aqueous medium, said aqueous medium containing hydrogen peroxide and a buffer to maintain the pH of the composition at less than 7.
The object of the present invention is to provide further improved dermatological compositions containing hydrogen peroxide.
According to the invention therefore there is provided a dermatological composition in the form of a single phase aqueous gel containing hydrogen peroxide and a buffer to maintain the pH of the composition at less than 7.
With this composition, due to the incorporation of the hydrogen peroxide in an aqueous gel preparation and due to the presence of the acid buffer it is possible to achieve surprisingly good dermatological activity with a relatively small proportion of hydrogen peroxide whereby the possibility of damage to the skin tissue can be avoided or at least appreciably minimised, and also it is possible to achieve a remarkable stability to the extent that such dermatological activity can be expected to be retained after an appreciable period of storage. The use of hydrogen peroxide in an aqueous gel also enables easy and intimate application to the skin.
In accordance with a preferred embodiment of the invention, the said single phase is nonlipid, and the composition is of the 'vanishing' kind and is free of all waxes, fats and oils.
Such composition when applied to the skin does not have an oily or greasy feel and is therefore particularly suitable for treating distressing skin conditions such as acne.
With regard to the buffer, this is preferably such as to maintain the pH at 2.5 to 6.5, particularly 2.5 to 3.2, and any suitable system may be used for this purpose. Thus, for example, there may be used an acid such as lactic acid, citric acid, tartaric acid, maleic acid, hydroxysuccinic acid with an acid salt.
Said acid salt may be any of sodium and potassium acid phosphate, sodium and potassium acid citrate, sodium and potassium acid tartrate.
Preferably the composition of the invention also incorporates a water-miscible volatile organic solvent. Such solvent may be an alcohol particularly an alkyl alcohol having 1 to 3 carbon atoms (expecially ethanol). Alternatively a ketone, particularly acetone may be used. The solvent can provide cleansing antiseptic and drying properties on the skin, and also can facilitate gel formation and water miscibility of other ingredients.
In order to achieve and maintain a stable gel structure, the composition may incorporate one or more gelling or thickening agents.
Suitable substances include the following: carboxy vinyl polymer (carboxy polymethylene), colloidal magnesium aluminium silicate, colloidal magnesium silicate, natural gums, starch (modified or unmodified and from various sources), cellulose derivatives (particularly hydroxy propylmethyl cellulose). In a particularly preferred embodiment a mixture of colloidal magnesium silicate and hydroxy propylmethyl cellulose is used.
Further, and in order to facilitate intimate contact between the hydrogen peroxide and the skin, the composition may incorporate a surface active agent which is soluble in the said single phase. Such surface agent is most preferably a non-ionic substance particularly polyoxyethylene 23 lauryl ether or polyoxyethylene 4 lauryl ether, although other surfactants (preferably but not necessarily polyoxyethylene or polyoxypropylene derivatives) may be used.
If desired, a humectant, such as propylene glycol, may be incorporated in the composition.
The composition of the invention may be manufactured by appropriate mixing of the ingredients with stirring and/or heating as required.
The above ingredients may be incorporated in the following proportions (all percentages being by weight): Hydrogen peroxide 0.75%-3.75%, preferably 0.75%-2% particularly 1.5% (based on 100% hydrogen peroxide although in practice hydrogen peroxide in say 30% aqueous solution may be used).
Solvent 1 % -50 %. Preferably 40% in the case of ethanol, 10% in the case of acetone.
Gelling Agent 0. 1%-7.5% (for each in the case where two substances are used in combination, a preferred combination being 1% hydroxypropyl methyl cellulose and 1% colloidal magnesium silicate).
Buffer system as required, say 0.5% acid salt with 0.5% acid.
Surfactant 5%-15% preferably 6%.
Humectant 2%-10% preferably 5%.
Water 10-80% preferably about 45%.
Of course, the invention is not restricted to the above seven ingredients: some of these may be omitted and others may be added.
In accordance with one Example of the invention, the following ingredients and proportions are used (ail percentages being by weight): Hydrogen peroxide 1.5% Ethanol 40% Hydroxypropyl methyl cellulose 1 % Colloidal magnesium silicate 1% Sodium acid phosphate 0.5% Lactic acid BP 0.5% Polyoxyethylene 23 iauryl ether 6% Propylene glycol 5% Water 44.5% This Example composition has good stability and is an effective and cosmetically acceptable preparation for use in the treatment of acne. It is of course to be understood that the invention is not intended to be restricted to the ingredients or proportions of the Example composition and, in addition it is to be appreciated that a composition according to the invention need not be used for the treatment of acne but may be used for the treatment of burns or for the treatment of any other suitable human or animal skin condition or for any other suitable dermatological purpose.

Claims (15)

1. A dermatological composition in the form of a single phase aqueous gel containing hydrogen peroxide and a buffer to maintain the pH of the composition at less than 7.
2. A composition according to claim 1, which is free of all waxes, fat and oils, said single phase being non-lipid.
3. A composition according to claim 1 or 2, which is buffered to a pH of 2.5 to 6.5.
4. A composition according to claim 3, wherein the pH is 2.5 to 3.2.
5. A composition according to any one of claims 1 to 4 wherein the buffer comprises an acid mixed with an acid salt.
6. A composition according to claim 5, wherein the acid is selected from lactic acid, citric acid, tartaric acid, maleic acid, hydroxysuccinic acid, and the acid salt is selected from sodium and potassium acid phosphate sodium and potassium acid citrate and sodium and potassium acid tartrate.
7. A composition according to any one of claims 1 to 6, further including a watermiscible volatile organic solvent.
8. A composition according to claim 7, wherein the solvent is an alcohol.
9. A composition according to claim 8, wherein the alcohol has 1 to 3 carbon atoms.
10. A composition according to claim 7, wherein the solvent is a ketone.
11. A composition according to claim 10, wherein the ketone is acetone.
1 2. A composition according to any one of claims 1 to 11, incorporating one or more gelling or thickening agents selected from: carboxy vinyl polymer, colloidal magnesium aluminium silicate, colloidal magnesium silicate, natural gums, starch, cellulose derivatives.
1 3. A composition according to claim 12, incorporating as a gelling or thickening agent a mixture of colloidal magnesium silicate and hydroxy propylmethyl cellulose.
14. A composition according to any one of claims 1 to 13, further including a surface active agent.
15. A composition according to.any one of claims 1 to 14, further including a humectant.
1 6. A composition according to any one of claims 1 to 15, containing 0.75%-3.75% by weight hydrogen peroxide.
1 7. A composition substantially as hereinbefore described in the Example.
GB8003430A 1980-06-09 1980-06-09 Dermatological compositions containing hydrogen peroxide Expired GB2068225B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB8003430A GB2068225B (en) 1980-06-09 1980-06-09 Dermatological compositions containing hydrogen peroxide
AU71426/81A AU7142681A (en) 1980-06-09 1981-06-09 Jet-pump dredge

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8003430A GB2068225B (en) 1980-06-09 1980-06-09 Dermatological compositions containing hydrogen peroxide

Publications (2)

Publication Number Publication Date
GB2068225A true GB2068225A (en) 1981-08-12
GB2068225B GB2068225B (en) 1983-12-14

Family

ID=10511056

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8003430A Expired GB2068225B (en) 1980-06-09 1980-06-09 Dermatological compositions containing hydrogen peroxide

Country Status (2)

Country Link
AU (1) AU7142681A (en)
GB (1) GB2068225B (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4781923A (en) * 1987-07-20 1988-11-01 Pellico Michael A Antiseptic gels
US4988500A (en) * 1989-09-29 1991-01-29 The Procter & Gamble Company Oral compositions
US5084268A (en) * 1991-06-17 1992-01-28 Dental Concepts, Inc. Tooth whitening dentifrice
EP0739209A1 (en) * 1993-12-17 1996-10-30 Albert M. Kligman Method for treatment of papulo-pustules and comedones of the skin
EP0862441A1 (en) * 1995-10-24 1998-09-09 Marshall University Research Corporation Vaginal pharmaceutical compositions containing a peroxide source
WO2000064255A1 (en) * 1999-04-27 2000-11-02 Grzegorz Nowakowski Pharmaceutical gel formulation
JP2007521238A (en) * 2002-07-01 2007-08-02 マリア ビラーニ, Sponge-based therapeutic compositions for the treatment and prevention of skin diseases
WO2013096580A2 (en) * 2011-12-23 2013-06-27 Gojo Industries, Inc. Foamable alcoholic compositions with skin benefits
JP2017513907A (en) * 2014-04-21 2017-06-01 アクラリス セラピューティクス、インク. Peroxide formulations and methods and applicators for their use

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4781923A (en) * 1987-07-20 1988-11-01 Pellico Michael A Antiseptic gels
US4988500A (en) * 1989-09-29 1991-01-29 The Procter & Gamble Company Oral compositions
US5084268A (en) * 1991-06-17 1992-01-28 Dental Concepts, Inc. Tooth whitening dentifrice
EP0739209A4 (en) * 1993-12-17 2000-04-12 Albert M Kligman Method for treatment of papulo-pustules and comedones of the skin
EP0739209A1 (en) * 1993-12-17 1996-10-30 Albert M. Kligman Method for treatment of papulo-pustules and comedones of the skin
EP0862441A1 (en) * 1995-10-24 1998-09-09 Marshall University Research Corporation Vaginal pharmaceutical compositions containing a peroxide source
EP0862441A4 (en) * 1995-10-24 1999-11-17 Marshall University Research C Vaginal pharmaceutical compositions containing a peroxide source
WO2000064255A1 (en) * 1999-04-27 2000-11-02 Grzegorz Nowakowski Pharmaceutical gel formulation
JP2007521238A (en) * 2002-07-01 2007-08-02 マリア ビラーニ, Sponge-based therapeutic compositions for the treatment and prevention of skin diseases
WO2013096580A2 (en) * 2011-12-23 2013-06-27 Gojo Industries, Inc. Foamable alcoholic compositions with skin benefits
WO2013096580A3 (en) * 2011-12-23 2014-10-09 Gojo Industries, Inc. Foamable alcoholic compositions with skin benefits
JP2017513907A (en) * 2014-04-21 2017-06-01 アクラリス セラピューティクス、インク. Peroxide formulations and methods and applicators for their use
US10493103B2 (en) 2014-04-21 2019-12-03 Aclaris Therapeutics, Inc. Peroxide formulations and methods and applicators for using the same
US10653721B2 (en) 2014-04-21 2020-05-19 Aclaris Therapeutics, Inc. Peroxide formulations and methods and applicators for using the same
US10729720B2 (en) 2014-04-21 2020-08-04 Aclaris Therapeutics, Inc. Peroxide formulations and methods and applicators for using the same

Also Published As

Publication number Publication date
GB2068225B (en) 1983-12-14
AU7142681A (en) 1981-12-17

Similar Documents

Publication Publication Date Title
US4056611A (en) Therapeutic composition
US3535422A (en) Stable benzoyl peroxide composition
US4387107A (en) Stable benzoyl peroxide composition
US4545990A (en) Anti-acne composition
US5925679A (en) Topical vehicles containing solubilized and stabilized azelaic acid
US3255082A (en) Method of preparing stable aluminum chlorhydrate-alkali metal- and alkaline earth metal salt complex antiperspirant stick
US5728391A (en) Hyaluronic acid and its salt for treating skin diseases
JP4286451B2 (en) Skin care composition with improved skin hydration
US4485091A (en) Dermatological compositions
CN106456543B (en) Leave-on chemical foam comprising benzoyl peroxide
US5017367A (en) Skin treatment preparation
JPS621287B2 (en)
EP0215108B1 (en) Compositions for treating acne vulgaris and methods of making same
HUT53518A (en) Process for producing skin moistening pharmaceutical composition comprising vitamins a as active ingredient
US4070451A (en) Hoof care emulsion or cream
GB2076286A (en) Dermatological hydrogen peroxide compositions
JPH0347252B2 (en)
US3530217A (en) Topical compositions comprising corn cob cellulose powder
US4203969A (en) Dithranol compositions for topical applications
GB2068225A (en) Dermatological compositions containing hydrogen peroxide
JPH0327532B2 (en)
JP2549119B2 (en) Topical
KR20160137593A (en) Non-rinse chemical mousse containing adapalene and benzoyl peroxide
KR102463133B1 (en) Cosmetic Composition Containing High-Content of Urea
JPS5869806A (en) Cosmetic lotion containing stable collagen

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19980201